Table of Contents

2019-2024 Global Influenza Diagnostics Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Influenza Diagnostics Consumption 2014-2024
  • 2.1.2 Influenza Diagnostics Consumption CAGR by Region
• 2.2 Influenza Diagnostics Segment by Type
  • 2.2.1 RIDT
  • 2.2.2 RT-PCR
  • 2.2.3 Cell Culture
• 2.3 Influenza Diagnostics Consumption by Type
  • 2.3.1 Global Influenza Diagnostics Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Influenza Diagnostics Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Influenza Diagnostics Sale Price by Type (2014-2019)
• 2.4 Influenza Diagnostics Segment by Application
  • 2.4.1 Hospitals
  • 2.4.2 POCT
  • 2.4.3 Others (Laboratory diagnosis, etc.)
• 2.5 Influenza Diagnostics Consumption by Application
  • 2.5.1 Global Influenza Diagnostics Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Influenza Diagnostics Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Influenza Diagnostics Sale Price by Application (2014-2019)

3 Global Influenza Diagnostics by Players

• 3.1 Global Influenza Diagnostics Sales Market Share by Players
  • 3.1.1 Global Influenza Diagnostics Sales by Players (2017-2019)
  • 3.1.2 Global Influenza Diagnostics Sales Market Share by Players (2017-2019)
• 3.2 Global Influenza Diagnostics Revenue Market Share by Players
  • 3.2.1 Global Influenza Diagnostics Revenue by Players (2017-2019)
  • 3.2.2 Global Influenza Diagnostics Revenue Market Share by Players (2017-2019)
• 3.3 Global Influenza Diagnostics Sale Price by Players
• 3.4 Global Influenza Diagnostics Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Influenza Diagnostics Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Influenza Diagnostics Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Influenza Diagnostics by Regions

• 4.1 Influenza Diagnostics by Regions
  • 4.1.1 Global Influenza Diagnostics Consumption by Regions
  • 4.1.2 Global Influenza Diagnostics Value by Regions
• 4.2 Americas Influenza Diagnostics Consumption Growth
• 4.3 APAC Influenza Diagnostics Consumption Growth
• 4.4 Europe Influenza Diagnostics Consumption Growth
• 4.5 Middle East & Africa Influenza Diagnostics Consumption Growth

5 Americas

• 5.1 Americas Influenza Diagnostics Consumption by Countries
  • 5.1.1 Americas Influenza Diagnostics Consumption by Countries (2014-2019)
  • 5.1.2 Americas Influenza Diagnostics Value by Countries (2014-2019)
• 5.2 Americas Influenza Diagnostics Consumption by Type
• 5.3 Americas Influenza Diagnostics Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Influenza Diagnostics Consumption by Countries
  • 6.1.1 APAC Influenza Diagnostics Consumption by Countries (2014-2019)
  • 6.1.2 APAC Influenza Diagnostics Value by Countries (2014-2019)
• 6.2 APAC Influenza Diagnostics Consumption by Type
• 6.3 APAC Influenza Diagnostics Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Influenza Diagnostics by Countries
  • 7.1.1 Europe Influenza Diagnostics Consumption by Countries (2014-2019)
  • 7.1.2 Europe Influenza Diagnostics Value by Countries (2014-2019)
• 7.2 Europe Influenza Diagnostics Consumption by Type
• 7.3 Europe Influenza Diagnostics Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Influenza Diagnostics by Countries
  • 8.1.1 Middle East & Africa Influenza Diagnostics Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Influenza Diagnostics Value by Countries (2014-2019)
• 8.2 Middle East & Africa Influenza Diagnostics Consumption by Type
• 8.3 Middle East & Africa Influenza Diagnostics Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Influenza Diagnostics Distributors
• 10.3 Influenza Diagnostics Customer

11 Global Influenza Diagnostics Market Forecast

• 11.1 Global Influenza Diagnostics Consumption Forecast (2019-2024)
• 11.2 Global Influenza Diagnostics Forecast by Regions
  • 11.2.1 Global Influenza Diagnostics Forecast by Regions (2019-2024)
  • 11.2.2 Global Influenza Diagnostics Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Influenza Diagnostics Forecast by Type
• 11.8 Global Influenza Diagnostics Forecast by Application

12 Key Players Analysis

• 12.1 BD
  • 12.1.1 Company Details
  • 12.1.2 Influenza Diagnostics Product Offered
  • 12.1.3 BD Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 BD News
• 12.2 Abbott (Include Alere)
  • 12.2.1 Company Details
  • 12.2.2 Influenza Diagnostics Product Offered
  • 12.2.3 Abbott (Include Alere) Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Abbott (Include Alere) News
• 12.3 Roche
  • 12.3.1 Company Details
  • 12.3.2 Influenza Diagnostics Product Offered
  • 12.3.3 Roche Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Roche News
• 12.4 SIEMENS
  • 12.4.1 Company Details
  • 12.4.2 Influenza Diagnostics Product Offered
  • 12.4.3 SIEMENS Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 SIEMENS News
• 12.5 Analytik Jena
  • 12.5.1 Company Details
  • 12.5.2 Influenza Diagnostics Product Offered
  • 12.5.3 Analytik Jena Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Analytik Jena News
• 12.6 Quidel
  • 12.6.1 Company Details
  • 12.6.2 Influenza Diagnostics Product Offered
  • 12.6.3 Quidel Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Quidel News
• 12.7 Thermo Fisher
  • 12.7.1 Company Details
  • 12.7.2 Influenza Diagnostics Product Offered
  • 12.7.3 Thermo Fisher Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Thermo Fisher News
• 12.8 Meridian Bioscience
  • 12.8.1 Company Details
  • 12.8.2 Influenza Diagnostics Product Offered
  • 12.8.3 Meridian Bioscience Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Meridian Bioscience News
• 12.9 BioMerieux
  • 12.9.1 Company Details
  • 12.9.2 Influenza Diagnostics Product Offered
  • 12.9.3 BioMerieux Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 BioMerieux News
• 12.10 Sekisui Diagnostics
  • 12.10.1 Company Details
  • 12.10.2 Influenza Diagnostics Product Offered
  • 12.10.3 Sekisui Diagnostics Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Sekisui Diagnostics News
• 12.11 Response Biomedical
• 12.12 SA Scientific
• 12.13 Enigma Diagnostics
• 12.14 Focus Diagnostics

13 Research Findings and Conclusion

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

The growth in the influenza diagnostic market is attributed to factors such as emergence of technologically advanced diagnostic tests with shorter turnaround time; initiatives by regulatory bodies, such as CDC’s seasonal influenza vaccination for prevention and control of seasonal influenza; and the demand created for influenza diagnosis in the flu season.

North America and Europe are the largest consumers in influenza diagnostics and is expected to retain the higher growth rate during the next years due to strong growth in influenza diagnostics industry. China has witnessed a major chunk in influenza diagnostics in the Asia Pacific region. Actually, that is why manufacturers have several plants, usually close to aimed demand market.
All manufactures in the world are committed to the improvement of products. These two years, some of Chinese manufactures can almost catch up with the world's leading technology too. Most technologies are developed by the manufacturers instead of importing from other companies.
Many international manufacturers expand their business through building factories or investments in targeted markets. Also, many major players have built up plants in other countries.

According to this study, over the next five years the Influenza Diagnostics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Influenza Diagnostics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Diagnostics market by product type, application, key manufacturers and key regions and countries.

This study considers the Influenza Diagnostics value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
RIDT
RT-PCR
Cell Culture
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
POCT
Others (Laboratory diagnosis, etc.)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
Enigma Diagnostics
Focus Diagnostics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Influenza Diagnostics consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Influenza Diagnostics market by identifying its various subsegments.
Focuses on the key global Influenza Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Influenza Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Influenza Diagnostics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.